CanSino Biologics (CanSino Biologics) Price-to-Tangible-Book : 1.03 (As of Jun. 04, 2024)

View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics Price-to-Tangible-Book?

As of today (2024-06-04), CanSino Biologics's share price is $2.83. CanSino Biologics's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $2.75. Hence, CanSino Biologics's Price to Tangible Book Ratio of today is 1.03.

The historical rank and industry rank for CanSino Biologics's Price-to-Tangible-Book or its related term are showing as below:

CASBF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.74 Med: 3.31 Max: 32.9
Current: 0.95

During the past 8 years, CanSino Biologics's highest Price to Tangible Book Ratio was 32.90. The lowest was 0.74. And the median was 3.31.

CASBF's Price-to-Tangible-Book is ranked better than
84.03% of 858 companies
in the Drug Manufacturers industry
Industry Median: 2.33 vs CASBF: 0.95

A closely related ratio is called PB Ratio. As of today, CanSino Biologics's share price is $2.83. CanSino Biologics's Book Value per Sharefor the quarter that ended in Mar. 2024 was $2.87. Hence, CanSino Biologics's P/B Ratio of today is 0.99.

CanSino Biologics Price-to-Tangible-Book Historical Data

The historical data trend for CanSino Biologics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Price-to-Tangible-Book Chart

CanSino Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

5.91

4.65

2.22

1.03

CanSino Biologics Quarterly Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial													-	0.98	0.98	1.03	0.68

Competitive Comparison of CanSino Biologics's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, CanSino Biologics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanSino Biologics's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanSino Biologics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where CanSino Biologics's Price-to-Tangible-Book falls into.

CanSino Biologics Price-to-Tangible-Book Calculation

CanSino Biologics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	2.83	/	2.745
	=	1.03

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

CanSino Biologics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

CanSino Biologics (CanSino Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (OTCPK:CASBF) » Definitions » Price-to-Tangible-Book

Traded in Other Exchanges

06185:Hong Kong CJH:Germany 688185:China

Address

185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN

Website

https://www.cansinotech.com

CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.